On October 14th, 2021, Somar filed a complaint with the United States International Trade Commission (ITC) requesting a 337 investigation. The complaint alleges that 38 companies and individuals in the United States, Canada, and other locations have infringed Somar's patents and trademarks. The company is seeking an exclusion order and a cease and desist order from the ITC.
A recent investigation was conducted involving three patents and one trademark related to Smoore's ceramic atomization technology. The patents include United States Patent Nos. 10,357,623, known as the "'623 Patent" which pertains to cotton-free liquid storage technology; 10,791,763, known as the "'763 Patent" which pertains to atomizer structural technology; and 10,791,762, known as the "'762 Patent" which pertains to ceramic heating element technology. The trademark involved is CCELL.
If the investigation finds that there has been infringement, the International Trade Commission (ITC) will prohibit the infringing company from selling their products in the United States, and will issue an exclusion order to Customs, preventing the importation of said products. Some defendants have already signed letters of agreement or settlement agreements.
On February 1st, 2023, the International Trade Commission (ITC) released a preliminary ruling regarding this case, stating that the 38 CBD vaporizer companies in question did not infringe upon three patents held by Smoller.
In the ruling notice, Chief Administrative Law Judge Clark Cheney wrote that certain atomizer pods or products containing atomizer pods that are imported or sold within the United States do not violate Section 337 of the Tariff Act of 1930.
Judgment Notification | Image Source: ITC
2FIRSTS will continue to report on this topic. Stay tuned for updates.
Reference:
The United States International Trade Commission
Simoer carries out 337 investigation in the United States, 17 foreign companies give in, included in the top 10 intellectual property events in Guangdong.
A trade agency is set to investigate cannabis vape companies following a complaint from CCell regarding a patent issue.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
